Tirzepatide activates two receptors (GLP-1 + GIP), making it the stronger option for stubborn weight resistance or insulin dysregulation
Understanding how side effects present when starting GLP-1 treatment can help you recognise what is normal versus concerning
There is still uncertainty about what happens after Bridge expires at the end of 2027, raising questions about whether beneficiaries who start treatment will be able to stay on it long term
Lastly, some evidence shows Ozempic could flare underlying illnesses for those prone to autoimmune conditions, leading to alopecia areata and patchy hair loss
If you have had gastric bypass, sleeve gastrectomy, or another bariatric procedure, work closely with your bariatric surgeon and prescribing provider during the transition
Images, graphics, and videos may not be reused without explicit written permission, unless they are clearly marked as Creative Commons licensed